Boltz
London, GB · 7 known investors
Boltz develops generative AI models for biomolecular design and drug discovery, used by researchers across pharmaceutical, biotech, agricultural, and academic sectors. The company offers frontier foundation models for protein and small-molecule design through an API with enterprise deployment options.
AI & Machine LearningBiotechDeep Tech
Founders & leadership
GC
Gabriele CorsoinCo-Founder and CEOGabriele completed his PhD at MIT from 2021 to 2025, working on machine learning for molecular and biological data. Earlier he was a machine learning researcher at Twitter, a quantitative researcher at The D. E. Shaw Group, and held engineering and research roles at Alchera Technologies, IBM, Sparkling Labs, and STMicroelectronics.
SP
Saro PassaroFounder
Investors · 7
Amplify PartnersMenlo Park · $500K – $5M
Andreessen HorowitzMenlo Park · $500K – $50M
Fifty YearsSan Francisco · $250K – $2M
Amplify Partners CVreportedMenlo Park
Factorial CapitalreportedBrooklyn · $500K
Obvious VenturesreportedSan Francisco · $250K – $6M
Zetta Venture Partnersreported · 2 sourcesSan Francisco · $1M – $5M
Funding
SEC filings, press & company announcements$28M disclosed across 1 of 2 rounds · 2026
- $28MseedJan 2026 · 3 sources
Amplify Partners (lead), Andreessen Horowitz (lead), Zetta Venture Partners (lead), Factorial Capital, Obvious Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Boltz went on to found or lead other companies.
Competitors · 4
by search overlap
Tamarind Bio26 shared keywordsTamarind provides a computational platform for protein and molecular engineering, offering AI and physics-based tools to design antibodies, peptides, enzymes, and small molecules. The platform integrates state-of-the-art published tools like AlphaFold and RFdiffusion through a user-friendly interface for life sciences companies.
Rowan Scientific23 shared keywordsRowan offers a web app and Python API for molecular design, simulation, and property prediction, including workflows for pKa, bond strength, redox potentials, protein-ligand binding affinity, and ADME properties. It serves drug discovery and materials science teams, letting them run computational chemistry workflows without maintaining their own compute infrastructure.
Hugging Face12 shared keywordsHugging Face is a collaboration platform that hosts and provides access to machine learning models, datasets, and applications. It offers both open-source tools for the ML community and paid compute and enterprise solutions for teams building AI applications.
Latent Space12 shared keywordsLatent Space is an AI-focused newsletter and technical podcast covering how AI labs build agents, models, infrastructure, and AI for science. It targets AI engineers and technical practitioners.
Companies competing with Boltz for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Boltz do?
- Boltz develops generative AI models for biomolecular design and drug discovery, used by researchers across pharmaceutical, biotech, agricultural, and academic sectors. The company offers frontier foundation models for protein and small-molecule design through an API with enterprise deployment options.
- Who founded Boltz?
- Boltz was founded by Gabriele Corso.
- Who are Boltz's investors?
- Boltz's investors include Amplify Partners, Andreessen Horowitz, Fifty Years, Amplify Partners CV, Factorial Capital, Obvious Ventures, Zetta Venture Partners.
- How much funding has Boltz raised?
- Boltz has disclosed $28M raised across 1 of its 2 known rounds.
- Where is Boltz headquartered?
- Boltz is headquartered in London, GB.